Thyroid C-mobile Tumors: In rodent reports, semaglutide is shown to cause thyroid C-cell tumors. It can be unidentified irrespective of whether this hazard applies to human beings, but semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or people with Numerous Endocrine Neoplasia syndrom